Cuffed endotracheal tube allows higher ventilation pressure in patients with poor pulmonary compliance, and it is used to monitor ventilation and tidal volume more accurately. The cuffed endotracheal tubes are designed to prevent the passage of fluid or air around the endotracheal tube. The uncuffed endotracheal tube has larger internal diameter compared to a cuffed tube. It also has lower resistance to air flow. The uncuffed endotracheal tube allows easy suctioning and prevents injuries in the subglottic region. Endotracheal intubation can lead to complications such as tooth avulsion, oral-pharyngeal laceration, laceration or hematoma of the vocal cords, upper airway and nasal trauma, tracheal laceration, perforation, hypoxemia, and intubation of the esophagus.
Increasing adoption of inorganic growth strategies such as mergers, agreements, and collaborations by key players operating in the market are expected to propel the market growth over the forecast period. For instance, in November 2017, Avanos Medical entered into a purchase agreement with Owens & Minor, Inc., a hospital service provider, in order to become the core franchise of its medical devices business segment. Moreover, in July 2018, Bactiguard entered into a new distribution agreement with Asid Bonz GmbH, a distributor of medical devices, to supply the Bactiguard Infection Protection (BIP) products in Germany.
Request for Analysis of COVID-19 Impact on Endotracheal Tube Market –
Manufacturers are focusing on development of innovative endotracheal tubes in order to prevent the hospital acquired infections. For instance, In February, N8 Medical, LLC submitted the Investigational Device Exemption (IDE) to the Food and Drug Administration (FDA) for the first-in-human clinical study of its CeraShield Endotracheal Tube (ETT). The objective of the clinical study is to evaluate the safety and efficacy of the CeraShield Endotracheal Tube (ETT).
However, increasing prevalence of hospital acquired infections such as ventilator associated pneumonia is expected to hinder the endotracheal tube market growth over the forecast period. For instance, according to the National Center for Biotechnology Information, in November 2017, each year in the U.S. ventilator-associated pneumonia (VAP) incidence range from 2 to 16 episodes per 1,000 ventilator-days.
By Product Type:
By End User:
- Ambulatory Surgical Centers
Request PDF Brochure Report –
If opting for the Global version of Endotracheal Tube Market analysis is provided for major regions as follows:
North America (The US, Canada, and Mexico)
Europe (the UK, Germany, France, and Rest of Europe)
Asia Pacific (China, India, and Rest of Asia Pacific)
Latin America (Brazil and Rest of Latin America)
Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa)
Reasons to Purchase this Report
Current and future of global Endotracheal Tube market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
Major Point Answered in Endotracheal Tube Market Research Study are:
What will be the progress rate of the Endotracheal Tube Market for the conjecture period, 2020-2027?
What are the prominent factors driving the Endotracheal Tube Market across different regions?
Who are the major vendors dominating the Endotracheal Tube industry and what are their winning strategies?
What will be the market scope for the estimated period?
What are the major trends shaping the expansion of the industry in the coming years?
What are the challenges faced by the Endotracheal Tube Market?
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027